National Headlines

JAMA Internal Medicine | Daily Low-Dose Aspirin, Risk of Serious Falls, Fractures in Healthy Older Adults

By on

A Substudy of the ASPREE Randomized Clinical Trial

Anna L. Barker, PhD1,2; Renata Morello, PhD1; Le Thi Phuong Thao, PhD1; et al Ego Seeman, MD3; Stephanie A. Ward, MBBS, MPH1,4; Kerrie M. Sanders, PhD5; Robert G. Cumming, MBBS, PhD6; Julie A. Pasco, PhD1,5,7; Peter R. Ebeling, MD8; Robyn L. Woods, PhD1; Rory Wolfe, PhD1; Sundeep Khosla, MD9; Sultana Monira Hussain, MBBS, PhD1,10; Kathlyn Ronaldson, MPH, DPhil1; Anne B. Newman, MD, MPH11; Jeff D. Williamson, MD, MHS12; John J. McNeil, MBBS, PhD1
Author Affiliations Article Information
JAMA Intern Med. Published online November 7, 2022. doi:10.1001/jamainternmed.2022.5028
Key PointsQuestion  Does daily low-dose aspirin reduce fractures and serious falls in healthy older people?

Findings  In this substudy of a randomized placebo-controlled trial, the risk of first fracture was similar in the aspirin and placebo groups, but the risk of serious fall was statistically significantly greater in the aspirin group (total falls 884 vs 804).

Meaning  The findings indicate a potential additional risk for the use of low-dose aspirin in older people.

READ MORE …

Citation

Barker AL, Morello R, Thao LTP, et al. Daily Low-Dose Aspirin and Risk of Serious Falls and Fractures in Healthy Older People: A Substudy of the ASPREE Randomized Clinical Trial. JAMA Intern Med. Published online November 07, 2022. doi:10.1001/jamainternmed.2022.5028

SOURCE: https://media.jamanetwork.com/news-item/analysis-of-failure-rates-for-covid-19-entrance-screening-at-an-academic-medical-center/

Categories: National Headlines